Diffusion Pharmaceuticals Inc. - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 25, 2016

Attached files

file filename
10-K - FORM 10-K - Diffusion Pharmaceuticals Inc.dffn20151231_10k.htm
EX-3.3 - EXHIBIT 3.3 - Diffusion Pharmaceuticals Inc.ex3-3.htm
EX-4.7 - EXHIBIT 4.7 - Diffusion Pharmaceuticals Inc.ex4-7.htm
EX-3.4 - EXHIBIT 3.4 - Diffusion Pharmaceuticals Inc.ex3-4.htm
EX-23.1 - EXHIBIT 23.1 - Diffusion Pharmaceuticals Inc.ex23-1.htm
EX-31.2 - EXHIBIT 31.2 - Diffusion Pharmaceuticals Inc.ex31-2.htm
EX-10.3 - EXHIBIT 10.3 - Diffusion Pharmaceuticals Inc.ex10-3.htm
EX-31.1 - EXHIBIT 31.1 - Diffusion Pharmaceuticals Inc.ex31-1.htm
EX-10.24 - EXHIBIT 10.24 - Diffusion Pharmaceuticals Inc.ex10-24.htm
EX-32.2 - EXHIBIT 32.2 - Diffusion Pharmaceuticals Inc.ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - Diffusion Pharmaceuticals Inc.ex32-1.htm

Exhibit 21.1

 

SUBSIDIARIES OF THE REGISTRANT

 

Name of Subsidiary

 

State or Other Jurisdiction
of Incorporation or
Organization

 

Direct or Indirect
Ownership Interest by
RestorGenex

 

Canterbury Laboratories, LLC

 

DE

 

100

%

Hygeia Therapeutics, Inc.

 

DE

 

100

%

Paloma Pharmaceuticals, Inc.

 

DE

 

100

%

VasculoMedics, Inc.

 

DE

 

100

%

Diffusion Pharmaceuticals LLC

 

VA

 

100

%

 

Diffusion Pharmaceuticals Inc. Reports